Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-11

Clinical Trial Update: Effect of Fluticasone Furoate/Vilanterol on EIA in Adolescents [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating the effect of Fluticasone Furoate/Vilanterol on exercise-induced asthma in adolescents, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Furoate/Vilanterol (fluticasone furoate/vilanterol)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Asthma in Children | Phase 4 | Status: COMPLETED